Navigation Links
Finance Committee Begins Markup - Lab Fee Converted to Medicare Cut
Date:9/23/2009

WASHINGTON, Sept. 23 /PRNewswire-USNewswire/ -- Yesterday the Senate Finance Committee started marking up the America's Healthy Future Act of 2009. The revised version of the bill circulated to the Committee deletes a special provider fee on laboratories and replaces it with an additional $5 billion cut in Medicare Part B payments to clinical laboratories.

The new version of the legislation does not specify how this latest reduction will be allocated. Mark Birenbaum, PhD, the Executive Director of the National Independent Laboratory Association (NILA) and the American Association of Bioanalysts (AAB), says that "If this additional cut is not allocated properly, the reduction will put many community laboratories including those serving nursing home patients, out of business, and give large corporate laboratories that have a small percentage of Medicare Part B work a huge competitive advantage. These large corporate laboratories are the same laboratories that stand to gain from increased enrollment due to health care reform."

Dr. Birenbaum says that the Finance Committee has made a commitment to work with the National Independent Laboratory Association (NILA), and AAB, and others in the laboratory community over the next several weeks to develop an appropriate way to allocate this additional cut to adjust the impact to reflect the amount of Medicare work performed. "The structure of this provision is critical to the future of the community laboratory. It is simply not fair to have the laboratories most involved in Medicare sustain another large cut. They will not survive if some adjustment is not made," says Dr. Birenbaum.

    CONTACT: Stephanie Nagy
    202-207-3637 snagy@prismpublicaffairs.com


'/>"/>
SOURCE National Independent Laboratory Association (NILA)
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals
2. Oxford Finance Corporation and GE Healthcare Financial Services Reaffirm Commitment to Biotech Sector in Europe
3. ISTO Technologies to Present at OneMedPlace Finance Forum
4. CryoLife to Present at OneMedPlace Finance Forum
5. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
6. DRI Capital Launches Structured Finance Fund
7. Wyeth Announces Executive Change in Finance Organization
8. Angiotech to participate in Credit Suisse Global Leveraged Finance Conference
9. Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections
10. Oxford Finance Corporation and Comerica Bank Provide $15 Million Loan Facility to VisualSonics Inc.
11. BioMS Medical to Participate in Speciality Panel Session at BioFinance 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... cancer research and personalized medicine, today announced the launch of a new breast ... Missouri. The study’s goal is to evaluate the potential for early detection of ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... and Electrospraying line of nanofiber and nanoparticle fabrication instruments ... the lab to fully automated pilot plants and equipment for industrial manufacturing. ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... While art ... are much more closely connected than one might think. A Mesh Is Also ... open at the University City Science Center’s Esther Klein Gallery (EKG) on August 17 ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... and Drug Administration (FDA) inspection at our Dilworth, MN site. The inspection took ... This inspection was conducted as part of a routine Bioresearch Monitoring Program (BIMO) ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... HONG KONG , March 30, 2017 ... developed a system for three-dimensional (3D) fingerprint identification by adopting ground ... technology into a new realm of speed and accuracy for use ... applications at an affordable cost. ... ...
Breaking Biology News(10 mins):